Comparing two methods of glaucoma drainage device implantation
Official title: Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Run by University of Pennsylvania · NCT05924477 · Data updated 2026-11-12
This study is testing whether placing a glaucoma drainage device in the front part of the eye or in a different spot helps people with glaucoma manage their eye pressure and cell health better over time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 226 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 8 sites (San Francisco, California and 7 other locations) |
| Status | Recruiting |
| Started | July 11, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT05924477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with medically uncontrolled glaucoma requiring a glaucoma drainage device.
✕Probably not a fit
Patients with preexisting corneal conditions or those who have undergone previous glaucoma surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The DECLARE Trial is a multi-center, randomized clinical trial designed to compare the effects of glaucoma drainage device (GDD) implantation in two different locations: the anterior chamber and the ciliary sulcus. This study aims to assess the impact of these placements on endothelial cell density and intraocular pressure over a 12-month follow-up period, with an extended follow-up of 24 months for additional outcomes. Participants will be randomly assigned to one of the two tube placement groups, ensuring balanced representation across clinical centers and surgical types. The trial employs a double-masked design to minimize bias in outcome assessment.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical techniques that minimize endothelial cell loss in glaucoma patients.
How similar studies have gone: Other studies have explored similar surgical techniques, but this specific comparison of tube placement locations is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Medically uncontrolled glaucoma requiring GDD or GDD combined with phacoemulsification as the planned surgical procedure * Candidate for GDD implantation for ciliary sulcus and AC tube * Age greater than or equal to 18 years old Exclusion Criteria: * Preexisting corneal condition that would affect the corneal endothelium or previous corneal transplant * Presence or history of Cypass Micro-Stent * Previous GDD, Xen Gel Stent or Preserflo MicroShunt removed less than 6 months before surgery * Presence of GDD implantation, Xen Gel Stent, of Preserflo MicroShunt * Previous trabeculectomy and/or minimally invasive glaucoma surgery within the past 6 months * AC intraocular lens * Presence of nanophthalmos, uncontrolled uveitis, silicone oil, Sturge-Weber syndrome or other conditions associated with elevated episcleral venous pressure * Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits * No light perception vision in the study eye or fellow eye visual acuity \< 20/200 * Need for glaucoma surgery combined with other ocular procedures (i.e. corneal transplant, or retinal surgery) or anticipated need for additional ocular surgery
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting -
Diablo Eye Associates
Walnut Creek, California, United States Recruiting -
Bascom Palmer Eye Institute
Miami, Florida, United States Recruiting -
Wilmer Eye Institute, Johns Hopkins University
Baltimore, Maryland, United States Recruiting -
Massachusetts Eye and Ear
Boston, Massachusetts, United States Recruiting -
University of Buffalo/State University of New York
Buffalo, New York, United States Recruiting
Show 2 more locations
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States Recruiting -
Prism Eye Institute, University of Toronto
Toronto, Canada Recruiting
Study contacts
- Study coordinator: Gui-shuang Ying, PhD
- Email: gsying@pennmedicine.upenn.edu
- Phone: 215-615-1514
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.